Apogee Therapeutics, Inc.
USD132.67
+0.06 (+0.05%)
CEO
Michael Thomas Henderson
IPO Date
2023-07-14
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$132.72
Prev. Close
$132.61
Day Low
$132.66
Day High
$132.83
52W Low
$34.34
52W High
$133.16
Market Cap
$8.19B
Volume
1.46M
| 80,000 |
| $132.54 |
| 12 Jun 2026 | HENDERSON MICHAEL THOMAS | director, officer: Chief Executive Officer | S-Sale | Disposed | 6,770 | $82.21 |
| 12 Jun 2026 | HENDERSON MICHAEL THOMAS | director, officer: Chief Executive Officer | S-Sale | Disposed | 7,654 | $82.78 |
| 12 Jun 2026 | HENDERSON MICHAEL THOMAS | director, officer: Chief Executive Officer | S-Sale | Disposed | 1,080 | $84.18 |
| 12 Jun 2026 | HENDERSON MICHAEL THOMAS | director, officer: Chief Executive Officer | S-Sale | Disposed | 1,577 | $85.19 |
| 12 Jun 2026 | HENDERSON MICHAEL THOMAS | director, officer: Chief Executive Officer | S-Sale | Disposed | 2,305 | $86.27 |
| 12 Jun 2026 | HENDERSON MICHAEL THOMAS | director, officer: Chief Executive Officer | S-Sale | Disposed | 614 | $86.89 |
| 11 Jun 2026 | Fairmount Funds Management LLC | director | A-Award | Acquired | 7,657 | $85.00 |
| 11 Jun 2026 | Shah Nimish P | director | A-Award | Acquired | 7,657 | $85.00 |